Telomere length in interstitial lung diseases

Chest

Volumn 148, Issue 4, 2015, Pages 1011-1018

  Snetselaar, Reinier ^a   Van Moorsel, Coline H M ^a,b   Kazemier, Karin M ^a,b   Van Der Vis, Joanne J ^a   Zanen, Pieter ^a,b   Van Oosterhout, Matthijs F M ^a   Grutters, Jan C ^a,b  

^a ST ANTONIUS HOSPITAL   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

SURFACTANT PROTEIN C; TELOMERASE REVERSE TRANSCRIPTASE; RNA; TELOMERASE;

ADULT; AGED; ALLERGIC PNEUMONITIS; ARTICLE; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; COHORT ANALYSIS; CONNECTIVE TISSUE DISEASE ASSOCIATED INTERSTITIAL LUNG DISEASE; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; FIBROSING ALVEOLITIS; GENE; GENE MUTATION; HUMAN; IDIOPATHIC NONSPECIFIC INTERSTITIAL PNEUMONIA; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SARCOIDOSIS; SFTPA2 GENE; SFTPC GENE; SMOKING; TELOMERE HOMEOSTASIS; TELOMERE SHORTENING; TERT GENE; GENETICS; MIDDLE AGED; MUTATION; RETROSPECTIVE STUDY; TELOMERE;

ADULT; AGED; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; RNA; TELOMERASE; TELOMERE;

EID: 84937025821     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-3078     Document Type: Article

References (43)

1. King TE Jr. Clinical advances in the diagnosis and therapy of the interstitial lung diseases. Am J Respir Crit Care Med. 2005; 172 (3): 268-279.
2. American Thoracic Society; European Respiratory Society. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002; 165 (2): 277-304.
3. Ryerson CJ, Collard HR. Update on the diagnosis and classification of ILD. Curr Opin Pulm Med. 2013; 19 (5): 453-459.
4. Alder JK, Chen JJ, Lancaster L, et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci U S A. 2008; 105 (35): 13051-13056.
5. Guan JZ, Maeda T, Sugano M, et al. An analysis of telomere length in sarcoidosis. J Gerontol A Biol Sci Med Sci. 2007; 62 (11): 1199-1203.
6. Cronkhite JT, Xing C, Raghu G, et al. Telomere shortening in familial and sporadic pulmonary fibrosis. Am J Respir Crit Care Med. 2008; 178 (7): 729-737.
7. Young NS. Telomere biology and telomere diseases: implications for practice and research. Hematology Am Soc Hematol Educ Program. 2010; 2010 : 30-35.
8. Armanios MY, Chen JJ, Cogan JD, et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med. 2007; 356 (13): 1317-1326.
9. Tsakiri KD, Cronkhite JT, Kuan PJ, et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci U S A. 2007; 104 (18): 7552-7557.
10. Alder JK, Stanley SE, Wagner CL, Hamilton M, Hanumanthu VS, Armanios M. Exome sequencing identifies mutant TINF2 in a family with pulmonary fibrosis. Chest. 2015 .147(5):1361-1368.
11. Cogan JD, Kropski JA, Zhao M, et al; University of Washington Center for Mendelian Genomics. Rare variants in RTEL1 are associated with familial interstitial pneumonia. Am J Respir Crit Care Med. 2015; 191 (6): 646-655.
12. Kropski JA, Mitchell DB, Markin C, et al. A novel dyskerin (DKC1) mutation is associated with familial interstitial pneumonia. Chest. 2014; 146 (1): e1-e7.
13. Albrecht E, Sillanpää E, Karrasch S, et al. Telomere length in circulating leukocytes is associated with lung function and disease. Eur Respir J. 2014; 43 (4): 983-992.
14. Belsky DW, Shalev I, Sears MR, et al. Is chronic asthma associated with shorter leukocyte telomere length at midlife? Am J Respir Crit Care Med. 2014; 190 (4): 384-391.
15. Haycock PC, Heydon EE, Kaptoge S, Butterworth AS, Thompson A, Willeit P. Leucocyte telomere length and risk of cardiovascular disease: systematic review and meta-analysis. BMJ. 2014; 349 : g4227.
16. Prescott J, Wentzensen IM, Savage SA, De Vivo I. Epidemiologic evidence for a role of telomere dysfunction in cancer etiology. Mutat Res. 2012; 730 (1-2): 75-84.
17. Kong CM, Lee XW, Wang X. Telomere shortening in human diseases. FEBS J. 2013; 280 (14): 3180-3193.
18. Armanios M. Telomeres and age-related disease: how telomere biology informs clinical paradigms. J Clin Invest. 2013; 123 (3): 996-1002.
19. Steele MP, Speer MC, Loyd JE, et al. Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med. 2005; 172 (9): 1146-1152.
20. Wang Y, Kuan PJ, Xing C, et al. Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. Am J Hum Genet. 2009; 84 (1): 52-59.
21. van Moorsel CH, van Oosterhout MF, Barlo NP, et al. Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a Dutch cohort. Am J Respir Crit Care Med. 2010; 182 (11): 1419-1425.
22. Tanjore H, Blackwell TS, Lawson WE. Emerging evidence for endoplasmic reticulum stress in the pathogenesis of idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2012; 302 (8): L721-L729.
23. Costabel U, Hunninghake GW; Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. ATS/ERS/WASOG statement on sarcoidosis. Eur Respir J. 1999; 14 (4): 735-737.
24. Raghu G, Collard HR, Egan JJ, et al; ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011; 183 (6): 788-824.
25. Travis WD, Costabel U, Hansell DM, et al; ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013; 188 (6): 733-748.
26. Cawthon RM. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res. 2009; 37 (3): e21.
27. Gansner JM, Rosas IO. Telomeres in lung disease. Transl Res. 2013; 162 (6): 343-352.
28. Holohan B, Wright WE, Shay JW. Cell biology of disease: telomeropathies: an emerging spectrum disorder. J Cell Biol. 2014; 205 (3): 289-299.
29. Kropski JA, Lawson WE, Young LR, Blackwell TS. Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis. Dis Model Mech. 2013; 6 (1): 9-17.
30. Liu T, Ullenbruch M, Young Choi Y, et al. Telomerase and telomere length in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2013; 49 (2): 260-268.
31. Stuart BD, Lee JS, Kozlitina J, et al. Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation. Lancet Respir Med. 2014; 2 (7): 557-565.
32. Armanios M, Blackburn EH. The telomere syndromes. Nat Rev Genet. 2012; 13 (10): 693-704.
33. Townsley DM, Dumitriu B, Young NS. Bone marrow failure and the telomeropathies. B lood. 2014; 124 (18): 2775-2783.
34. Valdes AM, Andrew T, Gardner JP, et al. Obesity, cigarette smoking, and telomere length in women. Lancet. 2005; 366(9486): 662-664.
35. Plunkett FJ, Franzese O, Belaramani LL, et al. The impact of telomere erosion on memory CD8 1 T cells in patients with X-linked lymphoproliferative syndrome. Mech Ageing Dev. 2005; 126 (8): 855-865.
36. Rufer N, Brümmendorf TH, Kolvraa S, et al. Telomere fluorescence measurements in granulocytes and T lymphocyte subsets point to a high turnover of hematopoietic stem cells and memory T cells in early childhood. J Exp Med. 1999; 190 (2): 157-167.
37. Effros RB, Allsopp R, Chiu CP, et al. Shortened telomeres in the expanded CD28-CD8 1 cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS. 1996; 10 (8): F17-F22.
38. Andrews NP, Fujii H, Goronzy JJ, Weyand CM. Telomeres and immunological diseases of aging. Gerontology. 2010; 56 (4): 390-403.
39. Mushiroda T, Wattanapokayakit S, Takahashi A, et al; Pirfenidone Clinical Study Group. A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis. J Med Genet. 2008; 45 (10): 654-656.
40. Minagawa S, Araya J, Numata T, et al. Accelerated epithelial cell senescence in IPF and the inhibitory role of SIRT6 in TGF- b -induced senescence of human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2011; 300 (3): L391-L401.
41. Coppé JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010; 5 : 99-118.
42. Alder JK, Guo N, Kembou F, et al. Telomere length is a determinant of emphysema susceptibility. Am J Respir Crit Care Med. 2011; 184 (8): 904-912.
43. Wuyts WA, Agostini C, Antoniou KM, et al. The pathogenesis of pulmonary fibrosis: a moving target. Eur Respir J. 2013; 41 (5): 1207-1218.